Edition:
United States

INSYS Therapeutics Inc (INSY.OQ)

INSY.OQ on NASDAQ Stock Exchange Global Market

12.80USD
23 Feb 2017
Change (% chg)

$-0.68 (-5.04%)
Prev Close
$13.48
Open
$13.61
Day's High
$13.67
Day's Low
$12.48
Volume
462,172
Avg. Vol
243,954
52-wk High
$21.21
52-wk Low
$8.70

Select another date:

Thu, Feb 16 2017

BRIEF-Neopharm to pay annual dividend as 350 won/share for FY 2016

* Says it will pay annual cash dividend as 350 won/share for FY 2016, to shareholders of record on Dec. 31, 2016

Insys to pay $3.4 million to resolve New Hampshire fentanyl drug probe

Insys Therapeutics Inc has agreed to pay $3.4 million to resolve claims by the New Hampshire attorney general that the company engaged in deceptive acts in connection with marketing a drug containing the opioid fentanyl through payments to a medical provider.

BRIEF-Insys Therapeutics announces retirement of Dr. John Kapoor as CEO

* Insys Therapeutics announces retirement of Dr. John n. Kapoor as ceo and chairman; appoints Dr. Santosh vetticaden as interim CEO and Steven Meyer as chairman of the board

Ex-Insys executives arrested for bribing U.S. doctors to prescribe painkiller

Six former Insys Therapeutics Inc executives and managers were arrested on Thursday on charges they engaged in a nationwide scheme to bribe doctors to unnecessarily prescribe a drug containing the opioid fentanyl, U.S. prosecutors said.

BRIEF-Insys Therapeutics posts Q3 adjusted EPS $0.07

* Q3 earnings per share view $0.02 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Ex-Insys employee charged with fraud scheme involving fentanyl drug

A former Insys Therapeutics Inc executive has been criminally charged for conspiring to defraud insurers into paying for a fentanyl-based cancer pain drug that was sometimes prescribed for off-label uses.

BRIEF-Insys Therapeutics reports preliminary estimated revenues from Subsys for Q3 2016 to be $54 mln -$55 mln

* Insys Therapeutics reports preliminary estimated revenues from subsys for the third quarter 2016

Ex-Insys sales manager arrested in U.S. fentanyl-kickback case

A former Insys Therapeutics Inc district sales manager was arrested on Thursday on charges he participated in a scheme to pay kickbacks to doctors to prescribe a drug containing the opioid fentanyl, U.S. prosecutors said.

Ex-Insys sales manager arrested in U.S. fentanyl-kickback case

A former Insys Therapeutics Inc district sales manager was arrested on Thursday on charges he participated in a scheme to pay kickbacks to doctors to prescribe a drug containing the opioid fentanyl, U.S. prosecutors said.

UPDATE 2-Ex-Insys sales manager arrested in U.S. fentanyl-kickback case

Sept 29 A former Insys Therapeutics Inc district sales manager was arrested on Thursday on charges he participated in a scheme to pay kickbacks to doctors to prescribe a drug containing the opioid fentanyl, U.S. prosecutors said.

Select another date:

More From Around the Web